• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找区分转移性乳腺癌与原发性肺癌的理想免疫组化套餐:一项对207例病例的组织芯片研究

In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 cases.

作者信息

Kawaguchi Kathy R, Lu Fang-I, Kaplan Rachel, Liu Yi-Fang, Chadwick Paul, Chen Zhengming, Brogi Edi, Shin Sandra J

机构信息

Departments of *Pathology and Laboratory Medicine ‡Public Health, Division of Biostatistics and Epidemiology, Weill Cornell Medical College †Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

出版信息

Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):266-74. doi: 10.1097/PAI.0b013e318297cc0b.

DOI:10.1097/PAI.0b013e318297cc0b
PMID:23958551
Abstract

BACKGROUND

Distinguishing metastatic carcinoma of breast origin (MCBO) to lung from primary lung carcinomas (PLC) is a diagnostic quandary with clinical ramifications. Immunostains CK7, CK20, ER, PR, and Mammaglobin as well as pertinent negative stains are utilized but prove insufficient. We set out to identify stains either alone or as a group that would better discern between these 2 entities.

DESIGN

Tissue microarrays of 109 MCBO to lung and 102 PLC were stained with CK7, CK20, ER, PR, AR, Mammaglobin, Napsin A, GATA-3, and TTF-1. An H-score was calculated for each case and stain.

RESULTS

The highest area under the receiver-operating characteristic curves for each stain was seen with GATA-3 (0.817), Napsin A (0.817), and TTF-1 (0.854). When all possible combinations were analyzed, GATA-3 and TTF-1 proved to correctly classify with the highest accuracy (0.934). Combinations of GATA-3 and Napsin A (0.920) and GATA-3, Napsin A, and TTF-1 (0.933) were not significantly different from GATA-3 and TTF-1. The odds ratios for each stain and combination of stains showed that those for GATA-3 and TTF-1 were divergent, signifying that cases with higher H-scores for GATA-3 and TTF-1 were more likely to be classified as MCBO and PLC, respectively.

CONCLUSIONS

GATA-3 and TTF-1 can correctly classify a case as either MCBO or PLC in 93.4% of cases. Although highly specific and sensitive for PLC, Napsin A in lieu of TTF-1 or as an additional stain did not improve classification accuracy.

摘要

背景

鉴别源自乳腺的肺转移癌(MCBO)与原发性肺癌(PLC)是一个具有临床影响的诊断难题。免疫组化染色使用细胞角蛋白7(CK7)、细胞角蛋白20(CK20)、雌激素受体(ER)、孕激素受体(PR)、乳腺珠蛋白以及相关的阴性染色,但证明并不充分。我们着手确定单独或作为一组能够更好区分这两种实体的染色方法。

设计

用CK7、CK20、ER、PR、雄激素受体(AR)、乳腺珠蛋白、 napsin A、GATA-3和甲状腺转录因子1(TTF-1)对109例MCBO和102例PLC的组织芯片进行染色。计算每个病例和每种染色的H评分。

结果

每种染色在受试者操作特征曲线下的最高面积见于GATA-3(0.817)、napsin A(0.817)和TTF-1(0.854)。当分析所有可能的组合时,GATA-3和TTF-1被证明以最高的准确率(0.934)正确分类。GATA-3和napsin A的组合(0.920)以及GATA-3、napsin A和TTF-1的组合(0.933)与GATA-3和TTF-1没有显著差异。每种染色和染色组合的优势比表明,GATA-3和TTF-1的优势比不同,这表明GATA-3和TTF-1的H评分较高的病例分别更有可能被分类为MCBO和PLC。

结论

GATA-3和TTF-1在93.4%的病例中可以正确地将病例分类为MCBO或PLC。尽管napsin A对PLC具有高度特异性和敏感性,但替代TTF-1或作为额外的染色并未提高分类准确率。

相似文献

1
In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 cases.寻找区分转移性乳腺癌与原发性肺癌的理想免疫组化套餐:一项对207例病例的组织芯片研究
Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):266-74. doi: 10.1097/PAI.0b013e318297cc0b.
2
Evaluating the utility of trefoil factor 1 as a mammary-specific immunostain compared and in conjunction with GATA-3 and mammaglobin in the distinction between carcinoma of breast and lung.评估三叶因子 1 作为乳腺特异性免疫标记物的效用,与 GATA-3 和 mammaglobin 联合用于鉴别乳腺癌和肺癌。
Am J Clin Pathol. 2015 Sep;144(3):444-51. doi: 10.1309/AJCPC7FA3IHYPEPF.
3
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.肺腺癌与乳腺癌免疫组织化学差异表达的研究。
Mod Pathol. 2010 May;23(5):654-61. doi: 10.1038/modpathol.2010.38. Epub 2010 Feb 19.
4
Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.TTF-1和Napsin-A在恶性胸腔积液检查中的应用价值。
Diagn Cytopathol. 2016 Apr;44(4):299-304. doi: 10.1002/dc.23442. Epub 2016 Jan 22.
5
Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.Napsin A是肺源性转移性腺癌的一种有用标志物。
Histopathology. 2014 Aug;65(2):195-206. doi: 10.1111/his.12383. Epub 2014 Mar 26.
6
Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.napsin A和TTF-1免疫组化联合应用有助于鉴别原发性肺腺癌与肺转移性癌。
Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):313-7. doi: 10.1097/PAI.0b013e318205b059.
7
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.三联标志物Napsin A、甲状腺转录因子-1(TTF-1)和配对盒基因8(PAX8)在鉴别原发性和转移性肺癌中的诊断效用。
Tumour Biol. 2016 Mar;37(3):3123-34. doi: 10.1007/s13277-015-3964-3. Epub 2015 Oct 1.
8
GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.GCDFP - 15阳性且TTF - 1阴性的原发性肺肿瘤:381例原发性肺肿瘤的组织芯片研究
Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):505-11. doi: 10.1097/PAI.0b013e3181a8e809.
9
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.PAX8、TTF-1和 napsin A在鉴别肺转移性癌与原发性腺癌中的诊断效用。
Biotech Histochem. 2012 Jan;87(1):30-4. doi: 10.3109/10520295.2011.591838. Epub 2011 Aug 15.
10
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. napsin A,一种新的肺腺癌标志物,在原发性肺癌的鉴别诊断中与甲状腺转录因子 1 相比具有互补性,且更敏感、更特异:应用组织微阵列技术检测 1674 例病例。
Arch Pathol Lab Med. 2012 Feb;136(2):163-71. doi: 10.5858/arpa.2011-0320-OA.

引用本文的文献

1
Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis.Bcl-xL 通过 CtBP2 易位到细胞核,从而表观遗传促进转移。
Cancer Lett. 2024 Nov 1;604:217240. doi: 10.1016/j.canlet.2024.217240. Epub 2024 Sep 10.
2
Mechanisms and Therapy for Cancer Metastasis to the Brain.癌症脑转移的机制与治疗
Front Oncol. 2018 May 24;8:161. doi: 10.3389/fonc.2018.00161. eCollection 2018.
3
Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma-case series and literature review.转移性非小细胞肺癌酷似原发性乳腺癌——病例系列与文献复习。
Virchows Arch. 2018 May;472(5):771-777. doi: 10.1007/s00428-017-2262-4. Epub 2017 Nov 5.